MODEL VERDICT
BrightSpring Health Services, Inc. Common Stock (BTSG)
Relative Valuation•Peer multiples, Monte Carlo simulation & quality-adjusted fair value
Popular:
Composite score derived from valuation, quality, and risk factors
Quantitative model thresholds · For educational and research purposes only
Each row records the model's monthly assessment. High Conviction = the model detected notable undervaluation vs peers. Neutral = no notable divergence was found. The return column shows the actual price change over 90 days for reference. This is a quantitative observation log — not investment advice.
| Date | Assessment | Score | Price | Status | 90d Fwd Return |
|---|---|---|---|---|---|
| May 1, 2026 | NEUTRAL | 0.12 | $52.58 | CURRENT | — |
| Apr 24, 2026 | NEUTRAL | 0.12 | $48.16 | CURRENT | — |
| Apr 17, 2026 | NEUTRAL | 0.12 | $47.27 | CURRENT | — |
| Apr 16, 2026 | NEUTRAL | 0.12 | $46.01 | CURRENT | — |
| Apr 10, 2026 | NEUTRAL | 0.14 | $45.33 | CURRENT | — |
Historical model observations for research purposes only. Past quantitative patterns do not predict future results. Not a recommendation to buy, sell, or hold any security.
| Methodology | Fair Value | vs Current | Weight | Quality | Status |
|---|---|---|---|---|---|
| Forward P/E 8 analyst estimates | $30.04 | -42.9% | 20% | A- | Analyst Est. |
| EV/EBITDA 9 industry peers | $15.63 | -70.3% | 20% | A- | Peer Data |
| EV/EBIT 8 industry peers | $9.51 | -81.9% | 8% | B+ | Peer Data |
| EV To Revenue 9 industry peers | $96.21 | +83.0% | 4% | B | Data |
| Price / Sales 9 industry peers | $83.49 | +58.8% | 3% | B | Model Driven |
| Weighted Output Blended model output | $30.70 | -41.6% | 100% | 50 | SIGNIFICANTLY OVERVALUED |
Cross-sectional regression predicting expected multiples based on growth, margins, ROIC, and beta.
Based on our peer multiples analysis with 11 valuation metrics, the model estimates BTSG's fair value at $30.70 vs the current price of $52.58, implying -41.6% downside potential. Model verdict: Significantly Overvalued. Confidence: 50/100. This is a quantitative estimate, not a recommendation.
The blended fair value of $30.70 is calculated using four lenses: industry median multiples (40%), historical multiples (30%), forward estimates (20%), and quality-adjusted multiples (10%). Monte Carlo simulation (10,000 iterations) gives a range of $19.57 (P10) to $40.37 (P90), with a median of $29.72.
BTSG's current P/E of -561.8x compares to the industry median of 19.9x (5 peers in the group). This represents a -2923.1% discount to the industry. The historical average P/E is N/Ax over 0 years. Signal: Deep Discount.
9 analysts cover BTSG with a consensus rating of Buy. The consensus price target is $48.75 (range: $43.00 — $60.00), implying -7.3% upside from the current price. Grade breakdown: Strong Buy (0), Buy (9), Hold (0), Sell (0), Strong Sell (0).
The model confidence score is 50/100, based on: data completeness (12), peer quality (25), historical depth (5), earnings stability (5), and model agreement (3). Cyclicality penalty: -0 points. The model shows moderate agreement across inputs.
The model flags several key risks: (1) Macro/regulatory risks are not captured in this model but remain material.
Peak earnings risk data is not available for BTSG.
No. This dashboard is a quantitative research tool for educational and informational purposes only. It is not investment advice, a solicitation, or a recommendation to buy, sell, or hold any security. The operator of this platform is not a registered investment advisor (RIA), broker-dealer, or financial planner. All model outputs, fair value estimates, signals, and scenarios are the result of automated quantitative computations and should not be construed as professional financial guidance. You should consult a qualified, licensed financial advisor before making any investment decisions. Past model performance is not indicative of future results.